- Home
- CEG vs SNY Comparison
CEG vs SNY Comparison
Compare CEG & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEG
- SNY
- Stock Information
- Founded
- CEG 1999
- SNY 1994
- Country
- CEG United States
- SNY France
- Employees
- CEG N/A
- SNY N/A
- Industry
- CEG Electric Utilities: Central
- SNY Biotechnology: Pharmaceutical Preparations
- Sector
- CEG Utilities
- SNY Health Care
- Exchange
- CEG Nasdaq
- SNY Nasdaq
- Market Cap
- CEG 108.2B
- SNY 116.1B
- IPO Year
- CEG N/A
- SNY N/A
- Fundamental
- Price
- CEG $360.34
- SNY $49.54
- Analyst Decision
- CEG Buy
- SNY Buy
- Analyst Count
- CEG 15
- SNY 4
- Target Price
- CEG $386.67
- SNY $61.50
- AVG Volume (30 Days)
- CEG 2.9M
- SNY 2.3M
- Earning Date
- CEG 11-07-2025
- SNY 10-24-2025
- Dividend Yield
- CEG 0.43%
- SNY 3.23%
- EPS Growth
- CEG N/A
- SNY 105.93
- EPS
- CEG 8.73
- SNY 8.67
- Revenue
- CEG $24,841,000,000.00
- SNY $53,890,648,839.00
- Revenue This Year
- CEG $2.82
- SNY $2.37
- Revenue Next Year
- CEG $7.64
- SNY $6.51
- P/E Ratio
- CEG $40.93
- SNY $5.71
- Revenue Growth
- CEG 3.58
- SNY N/A
- 52 Week Low
- CEG $161.35
- SNY $44.62
- 52 Week High
- CEG $412.70
- SNY $60.12
- Technical
- Relative Strength Index (RSI)
- CEG 50.71
- SNY 44.65
- Support Level
- CEG $333.75
- SNY $48.55
- Resistance Level
- CEG $351.98
- SNY $52.67
- Average True Range (ATR)
- CEG 16.68
- SNY 0.73
- MACD
- CEG -2.85
- SNY -0.09
- Stochastic Oscillator
- CEG 53.20
- SNY 23.94
About CEG Constellation Energy Corporation
Constellation Energy Corp producer of carbon-free energy and a supplier of energy products and services. The company offers generating capacity that includes nuclear, wind, solar, natural gas, and hydroelectric assets. It sells electricity, natural gas, and other energy-related products and sustainable solutions to various types of customers, including distribution utilities, municipalities, cooperatives, and commercial, industrial, public sector, and residential customers in markets across multiple geographic regions. Its operating segments and reporting units are Mid-Atlantic, Midwest, New York, ERCOT, and Other Power Regions.
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.